
Saving Sam
Drugs, Race, and Discovering the Secrets of Heart Disease
Jay Cohn(Author)
Calumet Editions (Publisher)
Published on 2. January 2023
Book
Paperback/Softback
304 pages
978-1-960250-04-9 (ISBN)
Description
A renowned physician and medical scientist reveals the secrets of heart disease-uncovered through 50 years of clinical investigation-that have revolutionized current management of heart disease and may eliminate it in the future. Richly illustrated with individual patient and experimental details, the book also weaves in the dramatic story of the development of the first drug approved specifically for African Americans, and how politics and misguided accusations of racism have tragically inhibited widespread use of this life-saving therapy.
More details
Language
English
Product notice
Paperback (trade)
Unsewn / adhesive bound
Dimensions
Height: 229 mm
Width: 152 mm
Thickness: 18 mm
Weight
496 gr
ISBN-13
978-1-960250-04-9 (9781960250049)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Person
Jay Cohn, M.D., is Professor of Medicine at the University of Minnesota Medical School and Director of the Rasmussen Center for Cardiovascular Disease Prevention. He was Director of the University's Cardiovascular Division from 1974-96. He is widely recognized for his contributions to an understanding of hypertension, coronary artery disease, myocardial infarction and heart failure. He is the author of over 750 scientific papers and has been honored by the American Heart Association, American College of Cardiology, American College of Physicians, American Society of Hypertension, Heart Failure Society of America, American Association for the Advancement of Science, Cornell University and the University of Minnesota for his research accomplishments. He has served as president of four national and international societies and is editor of a major textbook, Cardiovascular Medicine. He holds a number of patents on devices and drugs used to diagnose and treat cardiovascular disease.